Hemoximer pyridoxalated hemoglobin polyoxyethylene: Phase III ongoing

Curacyte said an independent DMB recommended continuation of the placebo-controlled, European Phase III PHOENIX trial based on interim analysis of safety and mortality data from half of the planned 45...